{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:40:21Z","timestamp":1792428021780,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.bcp.2022.115047","type":"journal-article","created":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T11:25:42Z","timestamp":1650367542000},"page":"115047","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Activation of CXCL13\/CXCR5 axis aggravates experimental autoimmune cystitis and interstitial cystitis\/bladder pain syndrome"],"prefix":"10.1016","volume":"200","author":[{"given":"Jiang","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengfei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bishao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingzheng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengshuai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qudong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longkun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenxing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanhong","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangshuang","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2022.115047_b0005","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejogrb.2013.12.041","article-title":"Interstitial cystitis\/painful bladder syndrome: epidemiology, pathophysiology and evidence-based treatment options","volume":"175","author":"Davis","year":"2014","journal-title":"Eur. J. Obstet Gynecol. Reprod. Biol."},{"issue":"2","key":"10.1016\/j.bcp.2022.115047_b0010","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.juro.2011.03.132","article-title":"Prevalence of symptoms of bladder pain syndrome\/interstitial cystitis among adult females in the United States","volume":"186","author":"Berry","year":"2011","journal-title":"J. Urol."},{"issue":"11-12","key":"10.1016\/j.bcp.2022.115047_b0015","doi-asserted-by":"crossref","first-page":"383","DOI":"10.5489\/cuaj.3892","article-title":"Depression and catastrophizing predict suicidal ideation in tertiary care patients with interstitial cystitis\/bladder pain syndrome","volume":"10","author":"Tripp","year":"2016","journal-title":"Can. Urol. Assoc. J."},{"key":"10.1016\/j.bcp.2022.115047_b0020","first-page":"25","article-title":"Pathology and terminology of interstitial cystitis\/bladder pain syndrome: A review","volume":"34","author":"Akiyama","year":"2019","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.bcp.2022.115047_b0025","doi-asserted-by":"crossref","unstructured":"E.P. Ward, S.N. Bartolone, M.B. Chancellor, K.M. Peters, L.E. Lamb, Proteomic analysis of bladder biopsies from interstitial cystitis\/bladder pain syndrome patients with and without Hunner's lesions reveals differences in expression of inflammatory and structural proteins, 20 (2020) 180.","DOI":"10.1186\/s12894-020-00751-x"},{"issue":"8","key":"10.1016\/j.bcp.2022.115047_b0030","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00192-010-1129-x","article-title":"Genome-based expression profiling study of Hunner's ulcer type interstitial cystitis: an array of 40-gene model","volume":"21","author":"Tseng","year":"2010","journal-title":"Int. Urogynecol. J."},{"key":"10.1016\/j.bcp.2022.115047_b0035","doi-asserted-by":"crossref","unstructured":"S.K. Saha, T.I. Jeon, Bioinformatics Approach for Identifying Novel Biomarkers and Their Signaling Pathways Involved in Interstitial Cystitis\/Bladder Pain Syndrome with Hunner Lesion, 9 (2020).","DOI":"10.3390\/jcm9061935"},{"issue":"1","key":"10.1016\/j.bcp.2022.115047_b0040","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1021\/pr5007729","article-title":"Urinary metabolite profiling combined with computational analysis predicts interstitial cystitis-associated candidate biomarkers","volume":"14","author":"Wen","year":"2015","journal-title":"J. Proteome Res."},{"issue":"6","key":"10.1016\/j.bcp.2022.115047_b0045","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMra052723","article-title":"The many roles of chemokines and chemokine receptors in inflammation","volume":"354","author":"Charo","year":"2006","journal-title":"N Engl. J. Med."},{"issue":"10","key":"10.1016\/j.bcp.2022.115047_b0050","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1358\/dnp.2002.15.10.740239","article-title":"The Role of Cytokines in the Initiation and Maintenance of Chronic Pain","volume":"15","author":"Rutkowski","year":"2002","journal-title":"Drug News Perspect"},{"key":"10.1016\/j.bcp.2022.115047_b0055","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.neures.2004.01.004","article-title":"Enhanced production of monocyte chemoattractant protein-1 in the dorsal root ganglia in a rat model of neuropathic pain: possible involvement in the development of neuropathic pain","volume":"48","author":"Tanaka","year":"2004","journal-title":"Neurosci. Res."},{"issue":"7","key":"10.1016\/j.bcp.2022.115047_b0060","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jpain.2005.02.001","article-title":"Induction of CX3CL1 expression in astrocytes and CX3CR1 in microglia in the spinal cord of a rat model of neuropathic pain","volume":"6","author":"Lindia","year":"2005","journal-title":"J. Pain"},{"issue":"10","key":"10.1016\/j.bcp.2022.115047_b0065","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nrd1852","article-title":"Chemokines: integrators of pain and inflammation","volume":"4","author":"White","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.bcp.2022.115047_b0070","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.bbi.2006.12.003","article-title":"CXCR4 chemokine receptor signaling mediates pain hypersensitivity in association with antiretroviral toxic neuropathy","volume":"21","author":"Bhangoo","year":"2007","journal-title":"Brain Behav. Immun."},{"issue":"6","key":"10.1016\/j.bcp.2022.115047_b0075","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/j.juro.2012.01.034","article-title":"Urinary chemokines as noninvasive predictors of ulcerative interstitial cystitis","volume":"187","author":"Tyagi","year":"2012","journal-title":"J. Urol."},{"issue":"7","key":"10.1016\/j.bcp.2022.115047_b0080","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00192-017-3547-5","article-title":"Comparison of inflammatory urine markers in patients with interstitial cystitis and overactive bladder","volume":"29","author":"Furuta","year":"2018","journal-title":"Int. Urogynecol. J."},{"issue":"3","key":"10.1016\/j.bcp.2022.115047_b0085","doi-asserted-by":"crossref","first-page":"F589","DOI":"10.1152\/ajprenal.00628.2009","article-title":"Expression and function of CXCL12\/CXCR4 in rat urinary bladder with cyclophosphamide-induced cystitis","volume":"298","author":"Arms","year":"2010","journal-title":"Am. J. Phys. Renal Physiol."},{"key":"10.1016\/j.bcp.2022.115047_b0090","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.autneu.2006.02.030","article-title":"Expression of fractalkine and fractalkine receptor in urinary bladder after cyclophosphamide (CYP)-induced cystitis","volume":"126-127","author":"Yuridullah","year":"2006","journal-title":"Auton Neurosci."},{"issue":"1","key":"10.1016\/j.bcp.2022.115047_b0095","doi-asserted-by":"crossref","first-page":"F111","DOI":"10.1152\/ajprenal.00139.2013","article-title":"Expression and function of CCL2\/CCR2 in rat micturition reflexes and somatic sensitivity with urinary bladder inflammation","volume":"305","author":"Arms","year":"2013","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"10.1016\/j.bcp.2022.115047_b0100","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/1471-2164-10-199","article-title":"Gene expression profile of bladder tissue of patients with ulcerative interstitial cystitis","volume":"10","author":"Gamper","year":"2009","journal-title":"BMC Genom."},{"issue":"1","key":"10.1016\/j.bcp.2022.115047_b0105","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s10753-018-0888-2","article-title":"The Effects of Neurokinin-1 Receptor Antagonist in an Experimental Autoimmune Cystitis Model Resembling Bladder Pain Syndrome\/Interstitial Cystitis","volume":"42","author":"Liu","year":"2019","journal-title":"Inflammation"},{"key":"10.1016\/j.bcp.2022.115047_b0110","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/S0022-5347(17)37091-X","article-title":"Experimental autoimmune cystitis: a potential murine model for ulcerative interstitial cystitis","volume":"148","author":"Bullock","year":"1992","journal-title":"J. Urol."},{"key":"10.1016\/j.bcp.2022.115047_b0115","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1111\/j.1476-5381.2009.00528.x","article-title":"The chemokine receptor antagonist, TAK-779, decreased experimental autoimmune encephalomyelitis by reducing inflammatory cell migration into the central nervous system, without affecting T cell function","volume":"158","author":"Ni","year":"2009","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2022.115047_b0120","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/01.tp.0000166338.99933.e1","article-title":"A novel small-molecule compound targeting CCR5 and CXCR3 prevents acute and chronic allograft rejection","volume":"80","author":"Akashi","year":"2005","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.bcp.2022.115047_b0125","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1183\/09031936.00111507","article-title":"A small-molecule compound targeting CCR5 and CXCR3 prevents airway hyperresponsiveness and inflammation","volume":"31","author":"Suzaki","year":"2008","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.bcp.2022.115047_b0130","doi-asserted-by":"crossref","first-page":"19670","DOI":"10.1038\/srep19670","article-title":"The c-Jun N-terminal kinase (JNK) pathway is activated in human interstitial cystitis (IC) and rat protamine sulfate induced cystitis","volume":"6","author":"Zhao","year":"2016","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.bcp.2022.115047_b0135","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1016\/j.juro.2008.01.082","article-title":"Nicotinic signaling ameliorates acute bladder inflammation induced by protamine sulfate or cyclophosphamide","volume":"179","author":"Starkman","year":"2008","journal-title":"J. Urol."},{"key":"10.1016\/j.bcp.2022.115047_b0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096801","article-title":"an open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples","volume":"9","author":"Varghese","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2022.115047_b0145","doi-asserted-by":"crossref","unstructured":"H. Zhang, J. Zhao, Q. Lu, B. Sun, X. Liu, C. Yang, S. Li, L. Li, S. Yi, Z. Yang, Luteolin Improves Cyclophosphamide-Induced Cystitis through TXNIP\/NLRP3 and NF-kappaB Pathways, 2021 (2021) 1718709.","DOI":"10.1155\/2021\/1718709"},{"key":"10.1016\/j.bcp.2022.115047_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114340","article-title":"Suppression of adenosine A(2a) receptors alleviates bladder overactivity and hyperalgesia in cyclophosphamide-induced cystitis by inhibiting TRPV1","volume":"183","author":"Yang","year":"2021","journal-title":"Biochem. Pharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2022.115047_b0155","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.ejca.2006.01.006","article-title":"Cancer CXC chemokine networks and tumour angiogenesis","volume":"42","author":"Strieter","year":"2006","journal-title":"Eur. J. Cancer"},{"issue":"5","key":"10.1016\/j.bcp.2022.115047_b0160","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1002\/1521-4141(200105)31:5<1544::AID-IMMU1544>3.0.CO;2-I","article-title":"BLC (CXCL13) is expressed by different dendritic cell subsets in vitro and in vivo","volume":"31","author":"Vissers","year":"2001","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bcp.2022.115047_b0165","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1186\/s13075-014-0434-z","article-title":"CXCL13 predicts disease activity in early rheumatoid arthritis and could be an indicator of the therapeutic 'window of opportunity'","volume":"16","author":"Greisen","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.bcp.2022.115047_b0170","doi-asserted-by":"crossref","unstructured":"Weili. Hui, Chenqi. Zhao, Sylvain. G. Bourgoin, LPA Promotes T Cell Recruitment through Synthesis of CXCL13. Mediators Inflamm 2015 (2015) 248492.","DOI":"10.1155\/2015\/248492"},{"issue":"9","key":"10.1016\/j.bcp.2022.115047_b0175","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/ncpuro0874","article-title":"Interstitial cystitis and systemic autoimmune diseases","volume":"4","author":"van de Merwe","year":"2007","journal-title":"Nat. Clin. Pract. Urol."},{"issue":"1","key":"10.1016\/j.bcp.2022.115047_b0180","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1074-7613(01)00257-6","article-title":"CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity","volume":"16","author":"Ansel","year":"2002","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.bcp.2022.115047_b0185","doi-asserted-by":"crossref","first-page":"5096","DOI":"10.4049\/jimmunol.168.10.5096","article-title":"CXCR5-transduced bone marrow-derived dendritic cells traffic to B cell zones of lymph nodes and modify antigen-specific immune responses","volume":"168","author":"Wu","year":"2002","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2022.115047_b0190","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/cei.12380","article-title":"Pathogenetic role of glomerular CXCL13 expression in lupus nephritis","volume":"178","author":"Worthmann","year":"2014","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.bcp.2022.115047_b0195","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1378\/chest.11-0633","article-title":"Role of CXCL13 in asthma: novel therapeutic target","volume":"141","author":"Baay-Guzman","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.bcp.2022.115047_b0200","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12974-016-0652-1","article-title":"Chemokine CXCL13 mediates orofacial neuropathic pain via CXCR5\/ERK pathway in the trigeminal ganglion of mice","volume":"13","author":"Zhang","year":"2016","journal-title":"J. Neuroinflammation"},{"issue":"10","key":"10.1016\/j.bcp.2022.115047_b0205","doi-asserted-by":"crossref","first-page":"5698","DOI":"10.1073\/pnas.96.10.5698","article-title":"A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity","volume":"96","author":"Baba","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.bcp.2022.115047_b0210","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1189\/jlb.0602269","article-title":"The unique target specificity of a nonpeptide chemokine receptor antagonist: selective blockade of two Th1 chemokine receptors CCR5 and CXCR3","volume":"73","author":"Gao","year":"2003","journal-title":"J. Leukoc Biol."},{"issue":"3","key":"10.1016\/j.bcp.2022.115047_b0215","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1006\/cyto.2001.0923","article-title":"Human B cell-attracting chemokine 1 (BCA-1; CXCL13) is an agonist for the human CXCR3 receptor","volume":"15","author":"Jenh","year":"2001","journal-title":"Cytokine"},{"issue":"4","key":"10.1016\/j.bcp.2022.115047_b0220","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1111\/j.1523-1755.2005.00244.x","article-title":"BCA-1\/CXCL13 expression is associated with CXCR5-positive B-cell cluster formation in acute renal transplant rejection","volume":"67","author":"Steinmetz","year":"2005","journal-title":"Kidney Int."},{"issue":"8","key":"10.1016\/j.bcp.2022.115047_b0225","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1093\/intimm\/dxh284","article-title":"The simultaneous blockade of chemokine receptors CCR2, CCR5 and CXCR3 by a non-peptide chemokine receptor antagonist protects mice from dextran sodium sulfate-mediated colitis","volume":"17","author":"Tokuyama","year":"2005","journal-title":"Int. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2022.115047_b0230","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1600-6143.2006.01584.x","article-title":"Quilty effect has the features of lymphoid neogenesis and shares CXCL13-CXCR5 pathway with recurrent acute cardiac rejections","volume":"7","author":"Di Carlo","year":"2007","journal-title":"Am. J. Transplant"},{"issue":"9","key":"10.1016\/j.bcp.2022.115047_b0235","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/ijcp.12116","article-title":"The urodynamic characteristics and prognostic factors of patients with interstitial cystitis\/bladder pain syndrome","volume":"67","author":"Kuo","year":"2013","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.bcp.2022.115047_b0240","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.urology.2016.04.018","article-title":"Differences in Urodynamic Parameters Between Women With Interstitial Cystitis and\/or Bladder Pain Syndrome and Severe Overactive Bladder","volume":"94","author":"Shim","year":"2016","journal-title":"Urology"},{"key":"10.1016\/j.bcp.2022.115047_b0245","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cellsig.2018.11.004","article-title":"How do chemokines navigate neutrophils to the target site: Dissecting the structural mechanisms and signaling pathways","volume":"54","author":"Rajarathnam","year":"2019","journal-title":"Cell Signal"},{"key":"10.1016\/j.bcp.2022.115047_b0250","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1242\/dev.101071","article-title":"Chemokine signaling in development and disease","volume":"141","author":"Wang","year":"2014","journal-title":"Development"},{"key":"10.1016\/j.bcp.2022.115047_b0255","doi-asserted-by":"crossref","unstructured":"Minke. Bekker, Shameemah. Abrahams, Ben. Loos, Soraya. Bardien, Can the interplay between autophagy and apoptosis be targeted as a novel therapy for Parkinson's disease? Neurobiol. Aging 100 (2021) 91\u2013105.","DOI":"10.1016\/j.neurobiolaging.2020.12.013"},{"key":"10.1016\/j.bcp.2022.115047_b0260","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.bbi.2019.05.020","article-title":"CXCL13\/CXCR5 signaling contributes to diabetes-induced tactile allodynia via activating pERK, pSTAT3, pAKT pathways and pro-inflammatory cytokines production in the spinal cord of male mice","volume":"80","author":"Liu","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bcp.2022.115047_b0265","doi-asserted-by":"crossref","unstructured":"M. Kvansakul, M. G. Hinds, Structural biology of the Bcl-2 family and its mimicry by viral proteins, Cell Death Dis 7 (2013) e909.","DOI":"10.1038\/cddis.2013.436"},{"key":"10.1016\/j.bcp.2022.115047_b0270","doi-asserted-by":"crossref","first-page":"931","DOI":"10.3389\/fnins.2018.00931","article-title":"Mechanisms Underlying Overactive Bladder and Interstitial Cystitis\/Painful Bladder Syndrome","volume":"12","author":"Grundy","year":"2018","journal-title":"Front Neurosci."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295222001411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295222001411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:34:54Z","timestamp":1757770494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295222001411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":54,"alternative-id":["S0006295222001411"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2022.115047","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activation of CXCL13\/CXCR5 axis aggravates experimental autoimmune cystitis and interstitial cystitis\/bladder pain syndrome","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2022.115047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115047"}}